News: Delivering a Better Future

Latest UM BioPark Tenant Seeks Partners for Testing of Cancer-Fighting Innovations > Read the UMB News Article

Ablitech moves to UMB BioPark, hiring for workers > View the Baltimore Business Journal

CEO Ken Malone gives pitch in Baltimore this week. > View the citybizlist

Ablitech Secures $2M DoD Grant to Develop siRNA Delivery Tech for Bone Condition > View the GenomeWeb News Article

Ablitech Gets $2M DoD Grant for R&D into Heterotopic Ossification > View the Genetic Engineering & Biotechnology News Article

Ablitech, Inc. Awarded $2 Million. Hattiesburg, Mississippi – Ablitech, Inc., a biotechnology company developing polymer-based delivery systems for gene silencing, today announced it has been awarded a $2 million grant by the U.S. Department of Defense (DoD). > Read More

Ablitech: An Early Pick At WBT Marketplace. Eleven “Early Picks” – undiscovered technologies originating from leading companies and research institutions around the world – have been pre-selected for the 2011 World’s Best Technology Innovation Marketplace (WBT).  Ablitech, Inc., a Hattiesburg-based biotechnology company, has received this honor after being screened by a panel of national seed investors, venture capitalists and corporate licensing executives. > Read More

Ablitech, Inc. To Help In Robotics Competition. Hattiesburg, Mississippi biotechnology company Ablitech, Inc. and Brookhaven, Mississippi school Enterprise Attendance Center are partnering to introduce students to future science endeavors.  Ablitech’s latest role – helping students participate in the eleventh annual First Lego League in the 2010 Body Forward Challenge. > Read More

Ablitech, Inc. Completes $700k Seed Capital Round. Hattiesburg, Mississippi – Ablitech, Inc., a biotechnology company specializing in delivering gene therapeutics  with the potential to stop cancer and most degenerative diseases, today announced completion of a $700,000 seed capital round. All funds were raised from within Mississippi. > Read More

Ablitech Launches New Web Site: Redesigned Look For All Backgrounds. Hattiesburg, MS – Ablitech, Inc. CEO, Ken Malone, today unveiled a new and interactive web site that will allow the public to appreciate the value of a gene delivery system having the potential to save thousands of lives through stopping a number of cancers and degenerative diseases. > Read More

Ablitech Receives Additional Investment Investment to help bring Disease-Fighting Versadel to Market Faster. Hattiesburg, Mississippi-based Noetic Technologies Chief Executive Officer Leslie Goff announced today that they have made a cash and strategic services investment into Ablitech, Inc. > Read More

Hattiesburg-Based Company Eyeing Ways to Stop Bladder Cancer: Positive Lab Data Yields Future Possibilities. Hattiesburg, Mississippi-based company, Ablitech’s CEO Ken Malone announced today that they are closer to advancing technology that has the ability to stop bladder cancer through their product Versadel. > Read More

Thousands of Lives May Be Saved With Technology To Stop Cancer: Versadel Does it Again. Ablitech, Inc., a biotechnology company dedicated to the development and commercializing of platform technologies that heal and protect the human body, announced today that their award-winning gene delivery technology, Versadel, has demonstrated the ability to turn off pancreatic cancer. > Read More